EGFR and head and neck squamous cell carcinoma: In order to evaluate the efficiency of several anti-EGFR drugs (including Cetuximab) on the same set of samples, we designed an in vitro screen of 25 well-characterized HNSCC cell lines that were classified as basal or non-basal.